Philippines vs Saudi Arabia: Prevalence rate of hypertension in adults aged 30-79
Philippines
33.8
in 2019
Saudi Arabia
34
in 2019
Philippines rank
133rd
Saudi Arabia rank
130th
Prevalence rate of hypertension in adults aged 30-79 over time
- Philippines
- Saudi Arabia
How they compare
Saudi Arabia currently reports 34 against 33.8 in Philippines, a difference of 0.2.
Across all 30 years both countries report, Saudi Arabia has been ahead every year.
Philippines ranks 133rd and Saudi Arabia ranks 130th of 194 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Philippines | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 30.01 | 34.78 | 4.77 | Saudi Arabia |
| 2000s | 32.16 | 35.07 | 2.91 | Saudi Arabia |
| 2010s | 33.44 | 34.37 | 0.93 | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Philippines or Saudi Arabia?
- Saudi Arabia, at 34 against 33.8 in Philippines as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Philippines and Saudi Arabia?
- 0.2, with Saudi Arabia ahead.
- How many years of comparable data are there for Philippines and Saudi Arabia?
- 30 years are reported by both, from 1990 to 2019.
- How do Philippines and Saudi Arabia rank globally for prevalence rate of hypertension in adults aged 30-79?
- Philippines ranks 133rd and Saudi Arabia ranks 130th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.